Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Temple syndrome is a less specific phenotype including intrauterine and postnatal growth restriction, hypotonia, feeding difficulties in infancy, truncal obesity, and small feet and hands. Temple syndrome is caused by defects or absence of paternally derived imprinting signals (including maternal UPD14).
Biomarker and diagnostic research for multiple congenital anomalies due to 14q32.2 paternally expressed gene defect has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
19 publications have been identified in PubMed for multiple congenital anomalies due to 14q32.2 paternally expressed gene defect. Research spans Case Report / Case Series (58%), Other (11%), and Review / Meta-Analysis (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 11 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 3:14 PM UTC
Other research | 2 | 11% |
Research summaries | 2 | 11% |
Laboratory research | 2 | 11% |
Testing and diagnosis research | 1 | 5% |
Disease patterns and progression | 1 | 5% |
Wang X (2026). [PMID: 42026594](https://pubmed.ncbi.nlm.nih.gov/42026594/). *BMC Pediatr*. [Case Report / Case Series]
Tobar M (2026). [PMID: 42098940](https://pubmed.ncbi.nlm.nih.gov/42098940/). *Am J Med Genet A*. [Other]
Narusawa H (2025). [PMID: 39324648](https://pubmed.ncbi.nlm.nih.gov/39324648/). *J Clin Endocrinol Metab*. [Basic Science / Preclinical]
D'Angelo E (2025). [PMID: 41276848](https://pubmed.ncbi.nlm.nih.gov/41276848/). *Clin Epigenetics*. [Basic Science / Preclinical]
Tanaka Y (2025). [PMID: 41137976](https://pubmed.ncbi.nlm.nih.gov/41137976/). *J Med Ultrason (2001)*. [Case Report / Case Series]
Peng H (2025). [PMID: 40229547](https://pubmed.ncbi.nlm.nih.gov/40229547/). *Sci Rep*. [Diagnostic / Biomarker]
Olsen T (2025). [PMID: 39667803](https://pubmed.ncbi.nlm.nih.gov/39667803/). *Clin Genet*. [Case Report / Case Series]
Braga BL (2025). [PMID: 39586716](https://pubmed.ncbi.nlm.nih.gov/39586716/). *Clin Genet*. [Review / Meta-Analysis]
Unknown (2025). [PMID: 40662577](https://pubmed.ncbi.nlm.nih.gov/40662577/). *J Clin Endocrinol Metab*. [Other]
Sá B (2025). [PMID: 40445129](https://pubmed.ncbi.nlm.nih.gov/40445129/). *Clin Dysmorphol*. [Case Report / Case Series]